Literature DB >> 10614958

Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in an immunocompetent host successfully treated with itraconazole: case report and review.

F Gutiérrez-Rodero1, M Moragón, V Ortiz de la Tabla, M J Mayol, C Martín.   

Abstract

Paecilomyces lilacinus is an emerging fungal pathogen that is highly resistant to many antifungal drugs. Skin and subcutaneous soft tissue infections caused by this organism are very unusual. Most cases occur in patients with impaired host defenses or following surgical procedures. There has been only one previous report of a histologically confirmed cutaneous infection due to Paecilomyces lilacinus in a patient without predisposing factors. Described here is the second histopathologically proven case of Paecilomyces lilacinus cutaneous infection in a healthy patient without any apparent portal of entry. Prolonged antifungal chemotherapy with itraconazole led to resolution of the skin lesion. This case of sporadic cutaneous infection due to Paecilomyces lilacinus is believed to be the first reported in Europe and the first histopathologically proven case successfully treated with itraconazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10614958     DOI: 10.1007/s100960050407

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections.

Authors:  F Gutiérrez; M Masiá; J Ramos; M Elía; E Mellado; M Cuenca-Estrella
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

Review 2.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; A Fothergill; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

4.  A Rare Case of Fungal Maxillary Sinusitis due to Paecilomyces lilacinus in an Immunocompetent Host, Presenting as a Subcutaneous Swelling.

Authors:  Harish S Permi; Kumar Y Sunil; Vimal K Karnaker; Prasad H L Kishan; S Teerthanath; Satheesh Kumar Bhandary
Journal:  J Lab Physicians       Date:  2011-01

5.  Paecilomyces lilacinus causing debilitating sinusitis in an immunocompetent patient: a case report.

Authors:  Gentle Wong; Robert Nash; Kushal Barai; Raksha Rathod; Arvind Singh
Journal:  J Med Case Rep       Date:  2012-03-26

Review 6.  Paecilomyces lilacinus vaginitis in an immuno-competent patient.

Authors:  Jeanne Carey; Ron D'Amico; Deanna A Sutton; Michael G Rinaldi
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

7.  Dapsone Induced Methemoglobinemia and Hemolysis in a G6PD Deficient Girl, Possibly Aggravated by Aggressive Methylene Blue Therapy.

Authors:  Tanmoy Ghatak; Banani Poddar; Arvind Kumar Baronia
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

8.  Cutaneous hyalohyphomycosis in an immunocompetent host.

Authors:  Vandana Mehta
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

9.  Pulmonary Paecilomyces in a Diabetic Patient.

Authors:  Sara Abolghasemi; Payam Tabarsi; Parvaneh Adimi; Arda Kiani; Samaneh Dolatshahi; Davood Mansouri
Journal:  Tanaffos       Date:  2015
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.